Evaluating only Science Exchange’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. That’s exactly how it died.
Key Events Timeline
FOUNDING
Elizabeth Iorns launches Science Exchange as YC-backed marketplace for outsourced research services.
FUNDING
Raises $18M Series B led by Andreessen Horowitz, valuing company at ~$100M.
LAYOFF
Team reduced by over 60% as enterprise pharma pipeline fails to close; platform activity drops sharply.
SHUTDOWN
Platform quietly winds down operations; marketplace taken offline after 12 years.
Full Analysis
Free · no account needed
Documented cause
Science Exchange raised $34M from Andreessen Horowitz and others to build a marketplace for outsourced scientific experiments. By 2022, the platform struggled to monetize academic users who expected free access. Enterprise pharma deals were too slow-closing and high-touch. CEO Elizabeth Iorns pivoted repeatedly but could not achieve sustainable unit economics. Staff was reduced to skeleton crew by late 2022 before the platform was quietly wound down in 2023.
Lesson
“Academic and enterprise sales cycles require separate products; trying to serve both simultaneously destroys focus.”